Both in Pharmaceuticals
Travere Therapeutics vs Dianthus Therapeutics
Over the past year TVTX returned +51.7% and DNTH returned +147.7%; their daily moves had a correlation of 0.32.
TVTX +51.7% DNTH +147.7%Growth of $1, one year, split-adjusted
| Metric | TVTX | DNTH |
|---|---|---|
| Price | $52.40 | $84.28 |
| Market cap | $4.94B | $4.71B |
| Today | +6.04% | +1.91% |
| 1 month | −6.4% | −1.3% |
| 6 months | +17.1% | −6.8% |
| Year to date | +37.1% | +104.5% |
| 1 year | +51.7% | +147.7% |
| Revenue growth (YoY) | +36.2% | +294.3% |
| Gross margin | 98.7% | 100.0% |
| Net margin | −23.3% | −6598.6% |
| P/E (TTM) | — | — |
| Price / sales | 7.6× | 2,475.9× |
| Net cash | -$131.7M | $886.8M |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 38.2% |
| Short % of float | 12.1% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).